These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9741568)

  • 1. Primary pulmonary hypertension associated with the use of fenfluramine derivatives.
    Simonneau G; Fartoukh M; Sitbon O; Humbert M; Jagot JL; Hervé P
    Chest; 1998 Sep; 114(3 Suppl):195S-199S. PubMed ID: 9741568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary pulmonary hypertension and fenfluramine use.
    Brenot F; Herve P; Petitpretz P; Parent F; Duroux P; Simonneau G
    Br Heart J; 1993 Dec; 70(6):537-41. PubMed ID: 8280518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.
    Souza R; Humbert M; Sztrymf B; Jaïs X; Yaïci A; Le Pavec J; Parent F; Hervé P; Soubrier F; Sitbon O; Simonneau G
    Eur Respir J; 2008 Feb; 31(2):343-8. PubMed ID: 17959632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.
    McCann UD; Seiden LS; Rubin LJ; Ricaurte GA
    JAMA; 1997 Aug; 278(8):666-72. PubMed ID: 9272900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The French are wary of their drugs].
    Nau JY
    Rev Med Suisse; 2011 May; 7(296):1170-1. PubMed ID: 21728251
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.
    Archer SL; Djaballah K; Humbert M; Weir KE; Fartoukh M; Dall'ava-Santucci J; Mercier JC; Simonneau G; Dinh-Xuan AT
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1061-7. PubMed ID: 9769261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminorex, dexfenfluramine, and primary pulmonary hypertension.
    Kramer MS; Lane DA
    J Clin Epidemiol; 1998 Apr; 51(4):361-4. PubMed ID: 9539893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iatrogenic pulmonary artery hypertension].
    Weitzenblum E; Kessler R; Chaouat A
    Rev Mal Respir; 1996; 13(2):133-9. PubMed ID: 8711232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Appetite depressant drugs and the risk of primary pulmonary hypertension].
    Olschewski H
    Pneumologie; 1997 Jun; 51(6):575-6. PubMed ID: 9333790
    [No Abstract]   [Full Text] [Related]  

  • 10. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension.
    Rich S; Rubin L; Walker AM; Schneeweiss S; Abenhaim L
    Chest; 2000 Mar; 117(3):870-4. PubMed ID: 10713017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anorectic drugs and pulmonary hypertension from the bedside to the bench.
    Michelakis ED; Weir EK
    Am J Med Sci; 2001 Apr; 321(4):292-9. PubMed ID: 11307870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension.
    Frank H; Mlczoch J; Huber K; Schuster E; Gurtner HP; Kneussl M
    Chest; 1997 Sep; 112(3):714-21. PubMed ID: 9315805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension associated with benfluorex exposure.
    Savale L; Chaumais MC; Cottin V; Bergot E; Frachon I; Prevot G; Pison C; Dromer C; Poubeau P; Lamblin N; Habib G; Reynaud-Gaubert M; Bourdin A; Sanchez O; Tubert-Bitter P; Jaïs X; Montani D; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2012 Nov; 40(5):1164-72. PubMed ID: 22523367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.
    Abenhaim L; Moride Y; Brenot F; Rich S; Benichou J; Kurz X; Higenbottam T; Oakley C; Wouters E; Aubier M; Simonneau G; Bégaud B
    N Engl J Med; 1996 Aug; 335(9):609-16. PubMed ID: 8692238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autopsy findings of heart and lungs in a patient with primary pulmonary hypertension associated with use of fenfluramine and phentermine.
    Tomita T; Zhao Q
    Chest; 2002 Feb; 121(2):649-52. PubMed ID: 11834685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium.
    Delcroix M; Kurz X; Walckiers D; Demedts M; Naeije R
    Eur Respir J; 1998 Aug; 12(2):271-6. PubMed ID: 9727773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of survival in patients with pulmonary hypertension associated with fenfluramine to patients with primary pulmonary hypertension.
    Rich S; Shillington A; McLaughlin V
    Am J Cardiol; 2003 Dec; 92(11):1366-8. PubMed ID: 14636926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake.
    Loogen F; Worth H; Schwan G; Goeckenjan G; Lösse B; Horstkotte D
    Cor Vasa; 1985; 27(2-3):111-24. PubMed ID: 4028729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT(2B) receptor loss of function mutation in a patient with fenfluramine-associated primary pulmonary hypertension.
    Blanpain C; Le Poul E; Parma J; Knoop C; Detheux M; Parmentier M; Vassart G; Abramowicz MJ
    Cardiovasc Res; 2003 Dec; 60(3):518-28. PubMed ID: 14659797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension.
    Weir EK; Reeve HL; Johnson G; Michelakis ED; Nelson DP; Archer SL
    Chest; 1998 Sep; 114(3 Suppl):200S-204S. PubMed ID: 9741569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.